Nanoscale materials and devices hold great promise for advanced diagnostics, sensors, targeted drug delivery, smart drugs, screening and novel cellular therapies. The Nanotechnology Program at CSB develops, optimizes and validates creative approaches to diagnosis and treatment of human disorders. The Nanotechnology Program at CSB is funded through two NIH designated Centers of Excellence:
- Translation Program of Excellence in Nanotechnology (TPEN; HHSN268201000044C) funded through the National Heart Lung and Blood Institute (NHLBI).
- Center of Cancer Nanotechnology Excellence (CCNE; U54-CA119349) funded through the National Cancer Institute (NCI)
Both programs are multidisciplinary and interinstitutional involving investigators from MIT, Harvard University, Harvard Medical School, Harvard affiliated teaching hospitals and the Broad Institute.